Michael K. Gibson MD, PhD

After obtaining his MD from Johns Hopkins, Dr. Gibson completed an Osler Medical Residency and Medical Oncology Fellowship at Johns Hopkins Hospital while concurrently earning a Ph.D. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. He leads local and national therapeutic trials for aero-digestive cancers, all with translational laboratory components. His laboratory experiences at the National Cancer Institute and National Institute of Environmental Health Sciences led to a number of publications regarding hormone receptor biology and DNA repair, which led to his translational research focus. 

His national presence in the field of aero-digestive cancers includes: Leadership of the Upper GI Working Group of the Eastern Cooperative Oncology Group (through which he was the PI on E2205); membership on the NCI Esophago-Gastric Task Force; and membership on the Head and Neck Committee of the Radiation Therapy Oncology Group and service on the NCI Central IRB, Other roles at prior institutions include: Chairmanship of the Hillman Cancer Center (HCC) Data, Safety and Monitoring Committee, the HCC Protocol Review Committee, the University of Pittsburgh IRB and the HCC Clinical Research Oversight Committee (all at UPMC).